TGCMU
TMO icon

Titan Global Capital Management USA’s Thermo Fisher Scientific TMO Stock Holding History

Titan Global Capital Management USA’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4M Buy
29,202
+266
+0.9% +$144K 2.14% 18
2025
Q4 		$16.8M Sell
28,936
-236
-0.8% -$133K 2.4% 18
2025
Q3 		$14.1M Sell
29,172
-5,699
-16% -$2.65M 2.08% 19
2025
Q2 		$14.1M Sell
34,871
-1,812
-5% -$758K 2.23% 18
2025
Q1 		$18.3M Sell
36,683
-463
-1% -$251K 3.76% 14
2024
Q4 		$19.3M Sell
37,146
-872
-2% -$479K 2.93% 17
2024
Q3 		$23.5M Sell
38,018
-1,102
-3% -$652K 3.67% 12
2024
Q2 		$21.6M Sell
39,120
-422
-1% -$242K 3.45% 13
2024
Q1 		$23M Sell
39,542
-96
-0.2% -$53.9K 3.63% 11
2023
Q4 		$21M Buy
39,638
+288
+0.7% +$139K 4.31% 9
2023
Q3 		$19.9M Sell
39,350
-1,567
-4% -$835K 4.86% 5
2023
Q2 		$21.3M Sell
40,917
-531
-1% -$287K 5.06% 4
2023
Q1 		$23.9M Sell
41,448
-436
-1% -$246K 6.23% 2
2022
Q4 		$23.1M Sell
41,884
-3,668
-8% -$1.94M 6.56% 2
2022
Q3 		$23.1M Sell
45,552
-2,261
-5% -$1.27M 6.62% 3
2022
Q2 		$26M Sell
47,813
-958
-2% -$527K 6.32% 4
2022
Q1 		$28.8M Sell
48,771
-8,245
-14% -$4.74M 6.05% 6
2021
Q4 		$38M Buy
+57,016
New +$35.6M 6.3% 3

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Titan Global Capital Management USA's TMO Position: Q1 2026 in Review

Titan Global Capital Management USA increased its Thermo Fisher Scientific (TMO) stake by 0.92% in Q1 2026, buying an estimated $144K and bringing the position to 29,202 shares worth $14.4M. The position accounts for 2.14% of the portfolio, ranked #18.

Titan Global Capital Management USA first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $38M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Titan Global Capital Management USA held 29,202 shares of Thermo Fisher Scientific worth $14.4M as of Q1 2026.
  • Titan Global Capital Management USA bought 266 Thermo Fisher Scientific shares in Q1 2026, an estimated $144K.
  • Thermo Fisher Scientific made up 2.14% of Titan Global Capital Management USA's portfolio in Q1 2026, its #18 holding.
  • Titan Global Capital Management USA first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Titan Global Capital Management USA's Thermo Fisher Scientific position peaked at $38M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Titan Global Capital Management USA's 13F filing for Q1 2026, filed 7 May 2026.